About Cirrus Bio
Cirrus Bio is a Healthcare company based in Phoenix (United States) founded in 2021. Multi-omic solutions for disease diagnosis and management are developed. The company has since been acquired. Its focus areas include Life Sciences, Oncology, Medical Devices and Imaging. Its competitors include Prana Thoracic and Nano Mobile Healthcare; 1 of its 2 listed competitors has raised funding.
Company details
Cirrus Bio was founded in 2021 in Phoenix, United States, within the biotechnology sector. Multi-omic approaches are employed by the company, integrating artificial intelligence with technologies such as next-generation sequencing, gene expression analysis, and proteomics. Diagnostic solutions for lung cancer are created to support disease diagnosis and management. Operations focus on innovative tools for clinical applications in oncology.
- Headquarters Phoenix, United States
- Stage Acquired
- SectorsHealthcare
- Website cirrus.bio
Competitors of Cirrus Bio
Cirrus Bio has 2 listed competitors in our database, 1 of them funded. They include Prana Thoracic and Nano Mobile Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pranathoracic.com | 2022 | Houston, United States | $6M | A company focused on early intervention in lung cancer. | ||
| nanomobilehealthcare.com | 2015 | New York, United States | Online marketplace for electronics, fashion, and household items shopping. |
Detailed competitors of Cirrus Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Cirrus Bio (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cirrus Bio
Complete news archive for Cirrus Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cirrus Bio
Cirrus Bio was founded in 2021.
Cirrus Bio is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
Cirrus Bio was founded in 2021 in Phoenix, United States, within the biotechnology sector. Multi-omic approaches are employed by the company, integrating artificial intelligence with technologies such as next-generation sequencing, gene expression analysis, and proteomics. Diagnostic solutions for lung cancer are created to support disease diagnosis and management. Operations focus on innovative tools for clinical applications in oncology.
Cirrus Bio's top competitors include Prana Thoracic and Nano Mobile Healthcare.